亚洲精品国产v片在线观看,欧美v日韩v国产综合,亚洲av片一区二区三区不卡不,日韩欧美中文在线播放

行業(yè)產(chǎn)品

  • 行業(yè)產(chǎn)品

上海經(jīng)科化學科技有限公司


當前位置:上海經(jīng)科化學科技有限公司>>抗體>>流式抗體>>Human EGF Recombinant Protein Carrier-Free

Human EGF Recombinant Protein Carrier-Free

返回列表頁
參  考  價面議
具體成交價以合同協(xié)議為準

產(chǎn)品型號100 ug

品       牌

廠商性質(zhì)經(jīng)銷商

所  在  地上海市

聯(lián)系方式:李小姐查看聯(lián)系方式

更新時間:2017-08-04 04:00:24瀏覽次數(shù):853次

聯(lián)系我時,請告知來自 環(huán)保在線

經(jīng)營模式:經(jīng)銷商

商鋪產(chǎn)品:183條

所在地區(qū):上海上海市

聯(lián)系人:李小姐

產(chǎn)品簡介

Human EGF Recombinant Protein Carrier-Free
Also known as: Epidermal Growth Gactor
RUO: For Research Use Only. Not for use in diagnostic procedures.

詳細介紹

Description: EGF (Epidermal Growth Factor) is a member of the EGF-like family of proteins. It stimulates the growth and differentiation of fibroblasts and epithelial cells, and plays a role in the development and regeneration of various tissues. EGF, like many of the other members of this family, it is synthesized as a precursor protein that remains anchored to the cell surface. Release of the soluble form occurs through a process known as ectodomain shedding, which involves cleavage of the extracellular domain by the proteins disintegrin and ADAM17. EGF signals via EGF Receptor (EGFr, ErbB1, or HER1), which is a type 1 tyrosine kinase receptor and can also bind several other EGF-like proteins. Binding of EGF to EGFr triggers receptor dimerization, autophosphorylation, and internalization of the receptor-ligand complex. EGF and its receptor are often overexpressed in malignant tumors, and are considered potential targets for cancer therapy.


感興趣的產(chǎn)品PRODUCTS YOU ARE INTERESTED IN

環(huán)保在線 設計制作,未經(jīng)允許翻錄必究 .? ? ? Copyright(C)?2021 http://www.zuisujiong.cn,All rights reserved.

以上信息由企業(yè)自行提供,信息內(nèi)容的真實性、準確性和合法性由相關企業(yè)負責,環(huán)保在線對此不承擔任何保證責任。 溫馨提示:為規(guī)避購買風險,建議您在購買產(chǎn)品前務必確認供應商資質(zhì)及產(chǎn)品質(zhì)量。

會員登錄

×

請輸入賬號

請輸入密碼

=

請輸驗證碼

收藏該商鋪

登錄 后再收藏

提示

您的留言已提交成功!我們將在第一時間回復您~
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |